NORTH BILLERICA, MA / ACCESS Newswire / July 28, 2025 / Tecogen Inc. (NYSE American:TGEN) a leading manufacturer of clean ...

NEW YORK, NY / ACCESS Newswire / July 28, 2025 / For decades, sustainability markets operated like closed clubs-built by ...

NEW YORK, NY / ACCESS Newswire / July 29, 2025 / Europe is reaching a pivotal moment in its industrial transformation. And ...

Elis delivers very solid H1 2025 resultsElis leverages its resilient and sustainable business model to continue delivering profitable growth, despite a challenging macro environment in Europe ...

(Reuters) -British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...

Nasdaq and S&P 500 hit record highs on Wall Street on Tuesday, 29 July 2025, as investors focused on the second-quarter results and the upcoming US Federal Reserve (Fed) policy. Companies like Sofi, ...

Moderna (MRNA), once an unknown biotech firm, quickly rose to the top of the global vaccine market during the COVID-19 ...

Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $6.87. The announcement from United Therapeutics is eagerly anticipated, with investors seeking news of surpassing ...

According to TipRanks.com, Wasserman is a 4-star analyst with an average return of 11.2% and a 43.0% success rate. Wasserman covers the Healthcare sector, focusing on stocks such as Intensity ...

In terms of consensus rating, Incyte is in the middle compared to its peers. Incyte has the highest revenue growth among its peers. Incyte also has the highest gross profit. However, Incyte has the ...

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

Key points Health data are critical to health systems in Canada, but the potential of these data to be accessed and used by foreign entities for surveillance purposes without consent is concerning.